Ubs Group Ag Oncology Institute, Inc. Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.36 - $2.3 $14,043 - $23,749	10,326 New	10,326 $16,000
Q2 2023 Aug 11, 2023	SELL	$0.35 - $0.72 $3,193 - $6,569	-9,124 Reduced 79.08%	2,414 $1,000
Q1 2023 May 12, 2023	BUY	$0.48 - $1.7 $2,580 - $9,140	5,377 Added 87.27%	11,538 $7,000
Q4 2022 Feb 08, 2023	BUY	$0.88 - $5.22 $4,027 - $23,891	4,577 Added 288.95%	6,161 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.71 - $7.4 $760 - $7,925	1,071 Added 208.77%	1,584 $7,000
Q2 2022 Aug 10, 2022	BUY	$4.78 - $9.89 $2,452 - $5,073	513 New	513 $3,000
Q1 2022 May 16, 2022	SELL	$3.97 - $9.85 $7,380 - $18,311	-1,859 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.15 - $10.98 $11,432 - $20,411	1,859 New	1,859 $18,000

17.5M

Ticker TOI
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 73,495,504
Market Cap $11M
Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.